> Home > Newsroom

Imaging Hallmarks of Cancer Symposium

Champalimaud Foundation in partnership with the European School of Radiology (ESOR) Champalimaud Centre for the Unknown , Lisbon, October 28/29 2016

  1. 12.2.2016
    The target group of this symposium consists of radiologists, nuclear medicine physicians, radiation oncologists, medical oncologists and surgeons interested in furthering knowledge on the importance of state-of-the-art imaging and its role to multidisciplinary management of patients with lymphoma, multiple myeloma, breast, hepatobiliary, pancreatic and rectal cancer. This will be a two-day course aimed at providing an overview on the potential of imaging biomarkers for research and clinical use in oncology, identifying the challenges and potentials of imaging modalities to drive breakthroughs in cancer imaging and demonstrating the synergies that result from multidisciplinary interactions in oncologic care. The course will consist of 8 sessions including lectures and case-based interactive panel discussions.

    • to envision significant advances in cancer hallmarks
    • to provide an overview on the potential of imaging biomarkers for research and clinical use in oncology
    • to identify the challenges and potentials of imaging modalities to drive breakthroughs in cancer imaging
    • to demonstrate the synergies that result from multidisciplinary interactions in oncologic care

    Online registration available here.  

    Programme information available here.




  1. Go back

 

RSS feed

Keep up to date with the latest news on the Champalimaud Foundation by subscribing our RSS feed. RSS feed